- Visibility 101 Views
- Downloads 58 Downloads
- Permissions
- DOI 10.18231/pjms.v.15.i.2.433-437
-
CrossMark
- Citation
Prevalence of non-alcoholic fatty liver disease and left ventricular diastolic dysfunction in newly diagnosed type II diabetes mellitus: an observational, cross-sectional study
- Author Details:
-
Sona Kaushal
-
Neeraj Ganju
-
Kiran K Mokta
-
Jatinder K Mokta
-
Ramesh Gulepa *
Introduction: Diabetes mellitus with its micro and macro vascular complication is one of the most researched topic in diabetology, but emergence of non-alcoholic fatty liver disease (NAFLD) and left ventricular diastolic dysfunction (LVDD) as its major complications has been given due consideration recently. Several workers have studied NAFLD and LVDD in diabetes separately.
Aim and Objective: In our current study we estimated the prevalence of NAFLD and LVDD in patients of type II diabetes mellitus.
Materials and Methods: The study was carried out in the department of internal medicine, IGMC Shimla during July 2017 to June 2018. All patients underwent laboratory investigations, abdominal ultrasound for fatty liver and 2D Echocardiography for LVDD.
Results: A total of 208 newly diagnosed type II diabetic patients were enrolled. Among these 179 (86.05%) had NAFLD on ultrasound, 107 (51.4%) had LVDD on 2D ECHO and 107 (51.44%) had metabolic syndrome. Out of 107 patients with diastolic dysfunction, 100 (93.41%) had fatty liver, which was significant statistically (p-0.002).
Conclusion: It was concluded that prevalence of NAFLD and LVDD was alarmingly high in patients of type II diabetes mellitus, who had normal blood pressure (Normotensive). As NAFLD and LVDD are linked to high cardiovascular risk in diabetic patients, these patients should be screened for the same at the time of diagnosis of diabetes so that steps for cardiovascular risk modification can be taken.
References
- International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: 2015.
- American Diabetes Association. Classification and diagnosis of diabetes. Standards of medical care in diabetes 2019. Diabetes Care. 2019;42(Suppl 1):S13–28.
- Finck BN. Targeting metabolism, insulin resistance, and diabetes to treat nonalcoholic steatohepatitis. Diabetes. 2018;67(12):2485–93.
- Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57.
- Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22(6):775–7.
- Kalra S, Vithalani M, Gulati G, Kulkarni CM, Kadam Y, Pallivathukkal J, et al. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India. 2013;61(7):448–53.
- Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865–73.
- Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082–90.
- Patil VC, Patil HV, Shah KB, Vasani JD, Shetty P. Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function. J Cardiovasc Dis Res. 2011;2(4):213–22.
- Mogelvang R, Sogaard P, Pedersen SA, Olsen NT, Marott JL, Schnohr P, et al. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation. 2009;119(20):2679–85.
- Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol. 2001;87(3):320–3.
- Leite NC, Salles GF, Araujo ALE, Villela-Nogueira CA, Cardoso CRL. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int. 2009;29(1):113–9.
- Singh D, Das CJ, Baruah MP. Imaging of non alcoholic fatty liver disease: a road less travelled. Indian J Endocrinol Metab. 2013;17(6):990–5.
- Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358–67.
- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.
- Prashanth M, Ganesh HK, Vima MV, John M, Bandgar T, Joshi SR, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J Assoc Physicians India. 2009;57:205–10.
- Agarwal AK, Jain V, Singla S, Baruah BP, Arya V, Yadav R, et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India. 2011;59:351–4.
- Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut. 2004;53(7):1020–3.
- Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30(5):1212–8.
- Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS. Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(8):948–63.
- Patil MB, Burji NPA. Echocardiographic evaluation of diastolic dysfunction in asymptomatic type 2 diabetes mellitus. J Assoc Physicians India. 2012;60:23–6.
How to Cite This Article
Vancouver
Kaushal S, Ganju N, Mokta KK, Mokta JK, Gulepa R. Prevalence of non-alcoholic fatty liver disease and left ventricular diastolic dysfunction in newly diagnosed type II diabetes mellitus: an observational, cross-sectional study [Internet]. Panacea J Med Sci. 2025 [cited 2025 Oct 27];15(2):433-437. Available from: https://doi.org/10.18231/pjms.v.15.i.2.433-437
APA
Kaushal, S., Ganju, N., Mokta, K. K., Mokta, J. K., Gulepa, R. (2025). Prevalence of non-alcoholic fatty liver disease and left ventricular diastolic dysfunction in newly diagnosed type II diabetes mellitus: an observational, cross-sectional study. Panacea J Med Sci, 15(2), 433-437. https://doi.org/10.18231/pjms.v.15.i.2.433-437
MLA
Kaushal, Sona, Ganju, Neeraj, Mokta, Kiran K, Mokta, Jatinder K, Gulepa, Ramesh. "Prevalence of non-alcoholic fatty liver disease and left ventricular diastolic dysfunction in newly diagnosed type II diabetes mellitus: an observational, cross-sectional study." Panacea J Med Sci, vol. 15, no. 2, 2025, pp. 433-437. https://doi.org/10.18231/pjms.v.15.i.2.433-437
Chicago
Kaushal, S., Ganju, N., Mokta, K. K., Mokta, J. K., Gulepa, R.. "Prevalence of non-alcoholic fatty liver disease and left ventricular diastolic dysfunction in newly diagnosed type II diabetes mellitus: an observational, cross-sectional study." Panacea J Med Sci 15, no. 2 (2025): 433-437. https://doi.org/10.18231/pjms.v.15.i.2.433-437